PRMT5 and telomere syndrome: To confirm the prognostic value of PRMT5 expression, we analyzed the transcriptome data from 255 translocation-related STS samples and 389 complex genomic STS samples with annotated clinical data from the French Sarcoma Group (Fig. 1C and D).